Insights

Innovative Product Focus Callitas Therapeutics develops groundbreaking biomedical technologies for obesity, weight management, CBD/Cannabis delivery, and female health, positioning it to meet emerging consumer demands in health and wellness markets.

Strategic Acquisitions Recent acquisitions of assets like C-103 and Extrinsa offer opportunities to expand product portfolio and accelerate market entry, attracting partners interested in innovative obesity and wellness solutions.

Collaborative Partnerships Partnerships such as the one with BFS Innovations and Pure Leaf Group highlight potential avenues for co-marketing and distribution channels that can expedite the commercialization process.

Market Entry Opportunities Successful launch of ToConceive and other products indicates strong potential for sales expansion in fertility, weight management, and cannabis-related health sectors across North America.

Limited Revenue, High Growth Although current revenue is modest, the company's innovative pipeline and recent strategic moves suggest significant future growth opportunities, making it attractive for investors and partners seeking long-term value creation.

Similar companies to Callitas Therapeutics, Inc

Callitas Therapeutics, Inc Tech Stack

Callitas Therapeutics, Inc uses 8 technology products and services including RSS, MySQL, Twemoji, and more. Explore Callitas Therapeutics, Inc's tech stack below.

  • RSS
    Content Management System
  • MySQL
    Database
  • Twemoji
    Font Scripts
  • React
    Javascript Frameworks
  • Modernizr
    Javascript Libraries
  • HTTP/3
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • LiteSpeed
    Web Servers

Callitas Therapeutics, Inc's Email Address Formats

Callitas Therapeutics, Inc uses at least 1 format(s):
Callitas Therapeutics, Inc Email FormatsExamplePercentage
FLast@callitas.comJDoe@callitas.com
100%

Frequently Asked Questions

Where is Callitas Therapeutics, Inc's headquarters located?

Minus sign iconPlus sign icon
Callitas Therapeutics, Inc's main headquarters is located at Newport, Kentucky United States. The company has employees across 1 continents, including North America.

What is Callitas Therapeutics, Inc's official website and social media links?

Minus sign iconPlus sign icon
Callitas Therapeutics, Inc's official website is callitas.com and has social profiles on LinkedIn.

What is Callitas Therapeutics, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Callitas Therapeutics, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Callitas Therapeutics, Inc have currently?

Minus sign iconPlus sign icon
As of December 2025, Callitas Therapeutics, Inc has approximately 3 employees across 1 continents, including North America. Key team members include President & Ceo: J. T.. Explore Callitas Therapeutics, Inc's employee directory with LeadIQ.

What industry does Callitas Therapeutics, Inc belong to?

Minus sign iconPlus sign icon
Callitas Therapeutics, Inc operates in the Biotechnology Research industry.

What technology does Callitas Therapeutics, Inc use?

Minus sign iconPlus sign icon
Callitas Therapeutics, Inc's tech stack includes RSSMySQLTwemojiReactModernizrHTTP/3Google AnalyticsLiteSpeed.

What is Callitas Therapeutics, Inc's email format?

Minus sign iconPlus sign icon
Callitas Therapeutics, Inc's email format typically follows the pattern of FLast@callitas.com. Find more Callitas Therapeutics, Inc email formats with LeadIQ.

Callitas Therapeutics, Inc

Biotechnology ResearchKentucky, United States2-10 Employees

Formed in early 2015, Callitas Health Inc. is a clinical-stage company developing innovative technologies for obesity, weight management, CBD/Cannabis delivery and female health and wellness. Founded on Midwest values, our Cincinnati-based company is people-focused, always looking for ways to benefit our customers, shareholders, and employees. Our company was built on strong work ethic, honesty, and a desire to help others.

Our number one goal is helping people by bringing products to market that improve quality of life. All our drug treatments and biomedical technologies fit our mission to deliver breakthrough products and services that reduce invasiveness and enhance daily living.

In addition to its recent acquisitions of C-103, a reformulation of Orlistat, Extrinsa, and assets from 40J’s LLC, Callitas successfully launched ToConceive in North America as a clinically proven option for couples struggling with the inability to conceive. www.toconceive.com.

Section iconCompany Overview

Headquarters
Newport, Kentucky United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $1M

    Callitas Therapeutics, Inc's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Callitas Therapeutics, Inc's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.